Working… Menu
Trial record 6 of 6 for:    UM1CA097452 OR UM1CA228823 | Recruiting Studies

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02323880
Recruitment Status : Recruiting
First Posted : December 24, 2014
Last Update Posted : July 18, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2021
Study Completion Date : No date given